TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31578781

Group type: EXPERIMENTAL
Intervention: Researcher-selected music
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Self-selected music
Number of subjects: 145

Group type: COMPARATOR
Intervention: Silent control condition
Number of subjects: 145

Group type: COMPARATOR
Intervention: Active control (listening to a radio show)
Number of subjects: 145
Study: 29747292

Group type: EXPERIMENTAL
Intervention: Early initiation of renal replacement therapy (RRT) in the ELAIN trial (KDIGO stage 2 of AKI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Late initiation of renal replacement therapy (RRT) in the ELAIN trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early and late groups of AKIKI trial
Number of subjects: 0
Study: 26449391

Group type: EXPERIMENTAL
Intervention: Single-dose i.v. fosaprepitant 150 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25050672

Group type: EXPERIMENTAL
Intervention: Two burr holes without a drain (Group I)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Single burr hole with a subdural drain (Group II)
Number of subjects: 140
Study: 22951160

Group type: EXPERIMENTAL
Intervention: Perioperative mitomycin C (MMC) instillation (40 mg MMC in 40 mL saline administered within 6 hours of surgery) followed by delayed BCG instillations (once a week for 6 weeks, 5 x 10^8 colony-forming units in 50 mL saline)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Delayed BCG instillations alone
Number of subjects: 51
Study: 20860912

Group type: EXPERIMENTAL
Intervention: Vildagliptin 10 mg twice daily
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Vildagliptin 25 mg twice daily
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg twice daily
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 18406674

Group type: EXPERIMENTAL
Intervention: Preperitoneal mesh repair (n=19)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lichtenstein repair (n=21)
Number of subjects: 40
Study: 15973955

Group type: EXPERIMENTAL
Intervention: Beta-tricalcium phosphate (Cerasorb)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Autogenous chin bone
Number of subjects: 10
Study: 12882841

Group type: EXPERIMENTAL
Intervention: Insulin (premixed 30% soluble and 70% NPH insulin, two daily injections)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Glibenclamide (3.5-10.5 mg daily)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Insulin (premixed 30% soluble and 70% NPH insulin, two daily injections) and Glibenclamide (3.5-10.5 mg daily)
Number of subjects: 39
Study: 10811082

Group type: EXPERIMENTAL
Intervention: Nd:YAG capsulotomy
Number of subjects: 6
Study: 8641491

Group type: EXPERIMENTAL
Intervention: Transvaginal aspiration of supernumerary follicles
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Low dosage of FSH (75 units daily)
Number of subjects: 227

Group type: COMPARATOR
Intervention: High dosage of FSH (150 units daily)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Overall multiple pregnancies
Number of subjects: 227
Study: 1729043

Group type: EXPERIMENTAL
Intervention: Reflection pulse oximeter
Number of subjects: 19

Group type: COMPARATOR
Intervention: Transmission pulse oximeter
Number of subjects: 19
Study: 4089097

Group type: EXPERIMENTAL
Intervention: Center field stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peripheral field stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contralateral stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ipsilateral stimuli
Number of subjects: 0
Study: 31310319

Group type: EXPERIMENTAL
Intervention: Genetically higher serum parathyroid hormone (S-PTH) concentrations
Number of subjects: 184305
Study: 30959067

Group type: COMPARATOR
Intervention: Sympathetic ophthalmia (SO)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Vogt–Koyanagi–Harada (VKH) disease
Number of subjects: 631
Study: 28359614

Group type: EXPERIMENTAL
Intervention: Exercise for Balance Improvement Program (ExBP)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Tai Chi (TC)
Number of subjects: 61
Study: 25886150

Group type: EXPERIMENTAL
Intervention: Tailored return to work intervention program (includes vocational rehabilitation and supportive psychosocial components, therapeutic placement at work)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Usual care provided by the Dutch Social Security Agency
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Tailored return to work intervention program
Number of subjects: 164
Study: 22739328

Group type: EXPERIMENTAL
Intervention: Sand training surface
Number of subjects: 10

Group type: COMPARATOR
Intervention: Grass training surface
Number of subjects: 10
Study: 22052142

Group type: EXPERIMENTAL
Intervention: Swedish massage (15 minutes, 3 times a week, for 3 months)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 19194150

Group type: EXPERIMENTAL
Intervention: Factor XIII (30 U/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 16341543

Group type: EXPERIMENTAL
Intervention: Fixed sequence stimulation of three digits of both hands
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random sequence stimulation of three digits of both hands
Number of subjects: 0
Study: 15515753

Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET
Number of subjects: 28

Group type: COMPARATOR
Intervention: 67Ga SPECT
Number of subjects: 28
Study: 11494096

Group type: EXPERIMENTAL
Intervention: 30 min of cycle ergometry at 70% VO(2Peak)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 30 min of quiet seated rest
Number of subjects: 8
Study: 9255751

Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐estradiol (0.05 mg/day once a week)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Oral norethisterone acetate (NETA) 1 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 8509588

Group type: EXPERIMENTAL
Intervention: Safflower oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Very-low-fat diet rich in lean beef
Number of subjects: 0
Study: 2893446

Group type: EXPERIMENTAL
Intervention: Naloxone 1 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naloxone 4 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Timolol 2 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29405174

Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation (GPR)
Number of subjects: 78
Study: 27387351

Group type: EXPERIMENTAL
Intervention: Duloxetine for 15 days
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo for 15 days
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 24462568

Group type: EXPERIMENTAL
Intervention: Cell Phone group
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Personal Coaching group
Number of subjects: 365

Group type: COMPARATOR
Intervention: Usual care, advice-only control condition
Number of subjects: 365
Study: 23648048

Group type: EXPERIMENTAL
Intervention: San Diego parks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Neighborhood walkability
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Neighborhood income
Number of subjects: 20

Group type: COMPARATOR
Intervention: Parks in Ghent
Number of subjects: 20
Study: 20021992

Group type: EXPERIMENTAL
Intervention: Overall obesity (BMI)
Number of subjects: 2547

Group type: EXPERIMENTAL
Intervention: Abdominal obesity (visceral fat)
Number of subjects: 2547

Group type: EXPERIMENTAL
Intervention: Visceral fat (adjusted for BMI)
Number of subjects: 2547

Group type: EXPERIMENTAL
Intervention: Persistent depressive symptoms
Number of subjects: 2547

Group type: COMPARATOR
Intervention: No associations found in women
Number of subjects: 2547
Study: 18361004

Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation (ECMO)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Case series of ECMO
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ECMO as rescue therapy
Number of subjects: 35
Study: 16875188

Group type: EXPERIMENTAL
Intervention: Surgery (carpal tunnel release)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment (immobilization, physiotherapy, drug therapy, steroid injections)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mini-invasive measures
Number of subjects: 0
Study: 12491501

Group type: EXPERIMENTAL
Intervention: CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone)
Number of subjects: 441

Group type: COMPARATOR
Intervention: L-PAM (L-phenylalanine mustard)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: CMFVP (in premenopausal women)
Number of subjects: 441

Group type: COMPARATOR
Intervention: L-PAM (in premenopausal women)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: CMFVP (in patients with > or = 4 positive lymph nodes)
Number of subjects: 441

Group type: COMPARATOR
Intervention: L-PAM (in patients with > or = 4 positive lymph nodes)
Number of subjects: 441
Study: 10375241

Group type: EXPERIMENTAL
Intervention: Myopia prevalence at age 6
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Myopia prevalence at age 12
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Myopia prevalence at age 15
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Myopia prevalence at age 16 to 18
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: High myopia prevalence at age 18
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Mean refractive status at age 18
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Axial length progression
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Anterior chamber depth (ACD)
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Corneal curvature
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Lens thickness progression
Number of subjects: 11178

Group type: EXPERIMENTAL
Intervention: Comparison of myopia severity between genders
Number of subjects: 11178
Study: 8942777

Group type: EXPERIMENTAL
Intervention: Peer review
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Editing
Number of subjects: 400
Study: 1497689

Group type: EXPERIMENTAL
Intervention: 40 mg ISMN in the morning
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: 20 mg ISMN b.i.d. morning and early afternoon
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 382
Study: 6128331

Group type: EXPERIMENTAL
Intervention: Piracetam (40 g, i.v.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (i.v.)
Number of subjects: 40
Study: 31711373

Group type: EXPERIMENTAL
Intervention: Healthy dietary pattern (highest category)
Number of subjects: 264211

Group type: EXPERIMENTAL
Intervention: Western dietary pattern (highest category)
Number of subjects: 264211

Group type: EXPERIMENTAL
Intervention: Healthy dietary pattern
Number of subjects: 264211

Group type: EXPERIMENTAL
Intervention: Western/unhealthy dietary pattern
Number of subjects: 264211
Study: 30742614

Group type: EXPERIMENTAL
Intervention: Improved sanitation intervention (pit latrine with plastic slab and drophole cover, child feces management tools)
Number of subjects: 2107

Group type: COMPARATOR
Intervention: Control (no sanitation intervention)
Number of subjects: 2107

Group type: EXPERIMENTAL
Intervention: Improved sanitation intervention
Number of subjects: 2107

Group type: COMPARATOR
Intervention: Control
Number of subjects: 2107
Study: 28408193

Group type: EXPERIMENTAL
Intervention: Imipramine (25-75 mg daily for 10 weeks)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 138
Study: 26337625

Group type: EXPERIMENTAL
Intervention: Home-based, task-specific upper limb training intervention
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Therapist-delivered sessions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Self-practice recommended for 42 hours
Number of subjects: 24
Study: 24399266

Group type: EXPERIMENTAL
Intervention: Household preparedness education through 'promotora' led small group meetings
Number of subjects: 187

Group type: COMPARATOR
Intervention: Household preparedness education through print media
Number of subjects: 187
Study: 18955605

Group type: EXPERIMENTAL
Intervention: Porcine model
Number of subjects: 49

Group type: COMPARATOR
Intervention: Manikin model
Number of subjects: 49
Study: 14996520

Group type: EXPERIMENTAL
Intervention: 0.004% travoprost
Number of subjects: 34

Group type: COMPARATOR
Intervention: 0.005% latanoprost
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 34
Study: 11759980

Group type: EXPERIMENTAL
Intervention: 50 mcg oral misoprostol every 4 hours
Number of subjects: 89

Group type: COMPARATOR
Intervention: 50 mcg oral misoprostol every 6 hours
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study: 9158880

Group type: EXPERIMENTAL
Intervention: Single-dose (SD) MDL 26479 ranging from 2 to 465 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple-dose (MD) MDL 26479 at doses of 30, 60, and 120 mg administered twice daily for 28 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose (SD) and multiple-dose (MD) MDL 26479
Number of subjects: 0
Study: 7962378

Group type: EXPERIMENTAL
Intervention: Pulsatile subcutaneous gonadotrophin administration
Number of subjects: 75

Group type: COMPARATOR
Intervention: Single daily bolus intramuscular gonadotrophin administration
Number of subjects: 75
Study: 3656939

Group type: EXPERIMENTAL
Intervention: High concentration dialysate (H; Na 154 mmol/liter)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low concentration dialysate (L; Na 126 mmol/liter)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Normal concentration dialysate (N; Na 140 mmol/liter)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Post-dialysis mean arterial pressure
Number of subjects: 12

Group type: COMPARATOR
Intervention: Heart rate during dialysis
Number of subjects: 12
Study: 11552204

Group type: EXPERIMENTAL
Intervention: Carbidopa L-dopa (Sinemet)
Number of subjects: 4
Study: 30659043

Group type: EXPERIMENTAL
Intervention: Access to remote, urgent, digital histopathology service
Number of subjects: 0
Study: 30423848

Group type: EXPERIMENTAL
Intervention: Low Glycaemic Index potato (Carisma® low GI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High Glycaemic Index potato (Arizona high GI)
Number of subjects: 20
Study: 26443493

Group type: EXPERIMENTAL
Intervention: Stepped care trauma-focused cognitive behavioral therapy (SC-TF-CBT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard trauma-focused cognitive behavioral therapy (TF-CBT)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both SC-TF-CBT and TF-CBT
Number of subjects: 53
Study: 24413262

Group type: EXPERIMENTAL
Intervention: Triple-antiretroviral prophylaxis among replacement-feeding mothers with baseline BMI at least 25
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Triple-antiretroviral prophylaxis among breastfeeding mothers who ceased breastfeeding before 3 months postpartum with baseline BMI at least 25
Number of subjects: 797

Group type: COMPARATOR
Intervention: Breastfeeding up to 6 months postpartum
Number of subjects: 797
Study: 22764364

Group type: EXPERIMENTAL
Intervention: Naltrexone implant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo implant
Number of subjects: 100
Study: 21400797

Group type: EXPERIMENTAL
Intervention: Patient-controlled epidural analgesia (PCEA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Continuous epidural infusion of analgesics and anaesthetics
Number of subjects: 42
Study: 18268929

Group type: EXPERIMENTAL
Intervention: tiotropium 5 microg Respimat
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: tiotropium 20 microg Respimat
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: tiotropium 18 microg HandiHaler
Number of subjects: 202

Group type: COMPARATOR
Intervention: placebo Respimat
Number of subjects: 202

Group type: COMPARATOR
Intervention: placebo HandiHaler
Number of subjects: 202
Study: 16044227

Group type: EXPERIMENTAL
Intervention: Palatally-displaced canines
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Unilaterally-affected patients
Number of subjects: 115
Study: 12390549

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 138
Study: 10426243

Group type: EXPERIMENTAL
Intervention: Paracervical block using 10 mL of 2% lignocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 100
Study: 7564725

Group type: EXPERIMENTAL
Intervention: Combined oral lysine acetylsalicylate (900 mg) and metoclopramide (10 mg)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Oral sumatriptan (100 mg)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Combined oral lysine acetylsalicylate and metoclopramide
Number of subjects: 421
Study: 2405540

Group type: EXPERIMENTAL
Intervention: Phadirect Strep A rapid test
Number of subjects: 257

Group type: COMPARATOR
Intervention: Cultivation at microbiological laboratories
Number of subjects: 257
Study: 6105569

Group type: EXPERIMENTAL
Intervention: Index group (24 trainees) received four sessions of individual instruction based on videotaped feedback.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (24 trainees) did not receive the intervention.
Number of subjects: 45
Study: 30768732

Group type: EXPERIMENTAL
Intervention: Eplerenone 50 mg/day (eGFR ≥ 50 mL/min/1.73 m2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eplerenone 25 mg/day (eGFR 30-49 mL/min/1.73 m2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (eGFR ≥ 50 mL/min/1.73 m2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (eGFR 30-49 mL/min/1.73 m2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eplerenone (eGFR 30-49 mL/min/1.73 m2)
Number of subjects: 0
Study: 27781307

Group type: EXPERIMENTAL
Intervention: 4 weeks heavy resistance training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Acute heavy resistance training
Number of subjects: 15
Study: 25700288

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) target <150 mm Hg
Number of subjects: 53

Group type: COMPARATOR
Intervention: Systolic blood pressure (SBP) target <180 mm Hg
Number of subjects: 53
Study: 23053684

Group type: EXPERIMENTAL
Intervention: Arthritis Self-Management Program (ASMP)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Arthritis Self-Management Program (ASMP) with attendance of four or more classes
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Arthritis Self-Management Program (ASMP) with attendance of less than four classes
Number of subjects: 104

Group type: COMPARATOR
Intervention: Both ASMP and usual care groups
Number of subjects: 104
Study: 21083585

Group type: EXPERIMENTAL
Intervention: Probiotics (given orally for 6 days preoperatively and 10 days post-operatively)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no probiotics)
Number of subjects: 100
Study: 20008376

Group type: EXPERIMENTAL
Intervention: Nellie the Elephant
Number of subjects: 130

Group type: COMPARATOR
Intervention: No music
Number of subjects: 130

Group type: COMPARATOR
Intervention: That's the Way (I like it)
Number of subjects: 130
Study: 17921531

Group type: EXPERIMENTAL
Intervention: Rapamycin-eluting stent
Number of subjects: 91

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent
Number of subjects: 91
Study: 15465627

Group type: EXPERIMENTAL
Intervention: Polymorphisms of genes located on chromosome 10 involved in cholesterol metabolism (LIPA, CH25H, FLJ22476)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control group (162 individuals without AD)
Number of subjects: 286
Study: 11460544

Group type: EXPERIMENTAL
Intervention: Glycolic acid cream (8% concentration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycolic acid cream (4% concentration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo cream (vehicle)
Number of subjects: 0
Study: 9879196

Group type: EXPERIMENTAL
Intervention: Hypotensive anesthesia with prostaglandin E1 (PGE1) and autologous blood transfusion (400 ml)
Number of subjects: 137
Study: 7980301

Group type: EXPERIMENTAL
Intervention: magnesium sulphate and nifedipine regimen
Number of subjects: 91

Group type: COMPARATOR
Intervention: lytic cocktail and nifedipine group
Number of subjects: 91
Study: 2498955

Group type: EXPERIMENTAL
Intervention: 0.15 mg clonidine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: saline
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.4 mg scopolamine
Number of subjects: 28
Study: 31679744

Group type: EXPERIMENTAL
Intervention: Empowerment-based transitional care program (6 weeks)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Attentional control (two general health education classes and post-discharge social calls)
Number of subjects: 242
Study: 31708253

Group type: EXPERIMENTAL
Intervention: Pityriasis Alba group (cases)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study: 29602555

Group type: EXPERIMENTAL
Intervention: General plus regional anesthesia
Number of subjects: 711

Group type: COMPARATOR
Intervention: Regional anesthesia alone
Number of subjects: 711
Study: 28974258

Group type: EXPERIMENTAL
Intervention: Intervention text messages about contraception and behaviour change methods delivered over 4 months.
Number of subjects: 570

Group type: COMPARATOR
Intervention: Control text messages about trial participation.
Number of subjects: 570
Study: 26665759

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy combined with Prolit super septo (10 day course)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard antibiotic therapy
Number of subjects: 120
Study: 24195622

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 9
Study: 21978016

Group type: EXPERIMENTAL
Intervention: CogniFit Personal Coach (CPC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reading Acceleration Program (RAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group of regular readers
Number of subjects: 0
Study: 19092036

Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Younger adults
Number of subjects: 0